Centrient Pharmaceuticals India Private Limited - Company Profile

It is a pharma private limited company based in Toansa, Punjab, India, established in 1993.
1993 Toansa, Punjab, India Active
Last Updated:
Access Report
About Centrient Pharmaceuticals India Private Limited

Centrient Pharmaceuticals India Private Limited, a active private limited company, was established on 19 January 1993 in Toansa, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231PB1993PTC023090. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹170.00 Cr and a paid-up capital of ₹160.30 Cr.

Formerly known as Dsm Sinochem Pharmaceuticals India Limited, Dsm Anti Infectives India Private Limited. It upholds a compliant status. Employing 613 professional, Its leadership includes Namit Joshi (Whole-Time Director), Vikram Aditya Sehgal (Cfo), Devesh Prakash Srivastava (Whole-Time Director). Past directors included Shalabh Goel, Ramanan Venkat Natarajan, Bhawna Singhal. It holds ₹200.00 Cr open charges and no settled loans. Its latest AGM occurred on 10 September 2025, with the balance sheet filed on 31 March 2025. It is based at Bhai Mohan Singh Nagar, Toansa, Punjab, 144533.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231PB1993PTC023090

  • Registration Number

    023090

  • Incorporation Date

    19 January 1993

  • Authorized Capital

    ₹170.00 Cr

  • Paid-Up Capital

    ₹160.30 Cr

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 170.00 Cr
  • Paid Up Capital ₹ 160.30 Cr
  • Company Age 33 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 200.00 Cr
  • Revenue Growth **** 13.46%
  • Profit Growth **** -31.41%
  • Ebitda **** -9.72%
  • Net Worth 8.75%
  • Total Assets **** 2.79%
Company report

Centrient Pharmaceuticals India Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Centrient Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Centrient Pharmaceuticals India Private Limited?
Current Directors
Name Designation Appointment Date Status
Namit Joshi Whole-Time Director 29 Jul 2021 Current
Vikram Aditya Sehgal Cfo 04 Jun 2021 Current
Devesh Prakash Srivastava Whole-Time Director 01 Apr 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Sep 2019 Past
Pramod Abcsdd Director 16 Nov 2009 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Cfo(Kmp) 31 May 2016 Past
Pramod Abcsdd Additional Director 14 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Centrient Pharmaceuticals India.

Centrient Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.46% increase. The company also saw a substantial fall in profitability, with a 31.41% decrease in profit. The company's net worth moved up by a moderate rise of 8.75%.

Centrient Pharmaceuticals India revenue growth over time
Centrient Pharmaceuticals India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13.46%
*******
*******
*******
*******
Revenue from Operations
*******
 13.90%
*******
*******
*******
*******
Total Assets
*******
 2.79%
*******
*******
*******
*******
Profit or Loss
*******
 -31.41%
*******
*******
*******
*******
Net Worth
*******
 8.75%
*******
*******
*******
*******
EBITDA
*******
 -9.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Centrient Pharmaceuticals India?

In 2023, Centrient Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,000,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 200.00 Cr
Latest Charge Details
Date Lender Amount Status
31 Oct 2018 Others ₹200.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Centrient Pharmaceuticals India?

Centrient Pharmaceuticals India has a workforce of 613 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Centrient Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centrient Pharmaceuticals India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Centrient Pharmaceuticals India
Recent Activity within the Organization
  • Annual General Meeting

    The activity Centrient Pharmaceuticals India Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Centrient Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 200.00 Cr registered on 31 Oct 2018 with Charge ID 100212988 was modified on 21 Jun 2024. was recorded as a recent event.

  • Director Appointment

    Progress on Devesh Prakash Srivastava was appointed as a Whole-time director was appointed as a Whole-time director on 01 Apr 2023 & has been associated with this company since 3 years 3 months . was documented.

  • Director Appointment

    Namit Joshi was appointed as a Whole-time director was appointed as a Whole-time director on 29 Jul 2021 & has been associated with this company since 4 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Vikram Aditya Sehgal was appointed as a CFO was appointed as a CFO on 04 Jun 2021 & has been associated with this company since 5 years 27 days . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Centrient Pharmaceuticals India Private Limited?

The CIN of Centrient Pharmaceuticals India Private Limited is U24231PB1993PTC023090.

Where is Centrient Pharmaceuticals India Private Limited headquartered?

Centrient Pharmaceuticals India Private Limited is headquartered at Bhai Mohan Singh Nagar, Toansa, Punjab, 144533.

When was Centrient Pharmaceuticals India Private Limited incorporated?

Centrient Pharmaceuticals India Private Limited was incorporated on 19 January 1993.

Who are the current directors of Centrient Pharmaceuticals India Private Limited?

The current directors of Centrient Pharmaceuticals India Private Limited are

What is the primary industry of Centrient Pharmaceuticals India Private Limited?

The primary industry of Centrient Pharmaceuticals India Private Limited is Manufacturing.

Is Centrient Pharmaceuticals India Private Limited a listed company?

Centrient Pharmaceuticals India Private Limited is unlisted.

What is the capital structure of Centrient Pharmaceuticals India Private Limited?

The authorized capital of Centrient Pharmaceuticals India Private Limited is ₹170.00 Cr, and the paid-up capital is ₹160.30 Cr.

What is the compliance status of Centrient Pharmaceuticals India Private Limited?

The compliance status of Centrient Pharmaceuticals India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available